Drug Industry - Bloomberg

DRUG INDUSTRY

Related Articles

Drugmakers Get Reprieve From Medicare Cost-Cutting Board
1 months ago

Drug Industry Deals Likely to Pick Up, Moody's Says
1 months ago

Senate Scrutiny of Nonprofits Spurring Disclosure: Taxes
1 months ago

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A
2 months ago

Novartis Cancer-Drug Patent Denied by India Supreme Court
2 months ago

Drugs for Indian Poor Spark Pfizer Anger at Lost Patents
2 months ago

Drugmaker ‘Pay for Delay’ Accords Questioned by Top Court
2 months ago

Bayer Joins Merck in Fighting Generic Drugs Case
2 months ago

Veeva Said to Plan IPO as Cloud Startup Challenges Oracle
3 months ago

Headache Cure Seen Helping Sanofi Gain Market: Corporate India
3 months ago

Glaxo Future Hangs in Balance on 2013 U.S. Drug Approvals
5 months ago

Pay for Delay, Dodd-Frank, Broker Bonuses: Compliance
6 months ago

Abbott, Casio, Tesco, Best Buy: Intellectual Property
6 months ago

‘Pay For Delay’ Drug Accords Get U.S. High Court Scrutiny
6 months ago

Generic Drug Accords Face Review by U.S. Supreme Court
6 months ago

Medtronic Wants Drug Industry Partners for Alzheimer’s
8 months ago

Drugmakers Don’t Owe Sales Force Overtime, Top Court Says
11 months ago

Obama Aides Helped Plan Ads to Back Health Bill, GOP Says
12 months ago

Merck, Pfizer Back Lawmakers Who Oppose Company Products
12 months ago

Mogul Using $100 Million in Race to Cure Daughter Lures Novartis
21 months ago

Show More News

PHOTOS

TOOLS
Watchlist | Stock Finder | Saved